Systemic retinoid therapy

被引:36
作者
DiGiovanna, JJ [1 ]
机构
[1] Brown Univ, Sch Med, Dept Dermatol, Div Dermatopathol, Providence, RI 02912 USA
关键词
D O I
10.1016/S0733-8635(05)70237-0
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Systemic retinoids are widely used in dermatology. They are among the most effective drugs available for several severe dermatoses. This article reviews the systemic retinoids, with particular reference to their use in dermatology. The history of their development and use, relevant compounds, their indications and toxicities, and how they are used in the management of severe skin disorders are explained and discussed.
引用
收藏
页码:161 / +
页数:8
相关论文
共 19 条
[1]   PREVENTION OF SKIN-CANCER AND REDUCTION OF KERATOTIC SKIN-LESIONS DURING ACITRETIN THERAPY IN RENAL-TRANSPLANT RECIPIENTS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
BAVINCK, JNB ;
TIEBEN, LM ;
VANDERWOUDE, FJ ;
TEGZESS, AM ;
HERMANS, J ;
TERSCHEGGET, J ;
VERMEER, BJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1933-1938
[2]   Etretinate may work where acitretin fails [J].
Bleiker, TO ;
Bourke, JF ;
GrahamBrown, RAC ;
Hutchinson, PE .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (03) :368-370
[3]   OSTEOPOROSIS IS A TOXIC EFFECT OF LONG-TERM ETRETINATE THERAPY [J].
DIGIOVANNA, JJ ;
SOLLITTO, RB ;
ABANGAN, DL ;
STEINBERG, SM ;
REYNOLDS, JC .
ARCHIVES OF DERMATOLOGY, 1995, 131 (11) :1263-1267
[4]   Posttransplantation skin cancer: Scope of the problem, management, and role for systemic retinoid chemoprevention [J].
DiGiovanna, JJ .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (06) :2771-2775
[5]   ETRETINATE - PERSISTENT SERUM LEVELS AFTER LONG-TERM THERAPY [J].
DIGIOVANNA, JJ ;
ZECH, LA ;
RUDDEL, ME ;
GANTT, G ;
PECK, GL .
ARCHIVES OF DERMATOLOGY, 1989, 125 (02) :246-251
[6]  
DIGIOVANNA JJ, 2000, IN PRESS J AM ACAD D
[7]   ETRETINATE TREATMENT OF THE NEVOID BASAL-CELL CARCINOMA SYNDROME - THERAPEUTIC AND CHEMOPREVENTIVE EFFECT [J].
HODAK, E ;
GINZBURG, A ;
DAVID, M ;
SANDBANK, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1987, 26 (09) :606-609
[8]   CLINICAL-RESPONSE AND TISSUE EFFECTS OF ETRETINATE TREATMENT OF PATIENTS WITH SOLAR KERATOSES AND BASAL-CELL CARCINOMA [J].
HUGHES, BR ;
MARKS, R ;
PEARSE, AD ;
GASKELL, SA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 18 (03) :522-529
[9]   PREVENTION OF SKIN-CANCER IN XERODERMA PIGMENTOSUM WITH THE USE OF ORAL ISOTRETINOIN [J].
KRAEMER, KH ;
DIGIOVANNA, JJ ;
MOSHELL, AN ;
TARONE, RE ;
PECK, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25) :1633-1637
[10]   13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A - EFFECTIVE COMBINATION THERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE SKIN [J].
LIPPMAN, SM ;
PARKINSON, DR ;
ITRI, LM ;
WEBER, RS ;
SCHANTZ, SP ;
OTA, DM ;
SCHUSTERMAN, MA ;
KRAKOFF, IH ;
GUTTERMAN, JU ;
HONG, WK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04) :235-241